SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Izzy who wrote (3439)12/27/1997 2:12:00 PM
From: Zirdu  Read Replies (2) | Respond to of 6136
 
If you sell for a $30,000 loss Monday, you can (1) offest these losses against any capital gains you have realized this year, from sales of stock, property, or capital gain distributions from mutual funds, and (2) if you still have losses left over, you can use up to $3,000 of the loss to offset ordinary income (i.e. like wages, etc.), and (3) if you still have losses left over, you can carry them over to next year and go through these three steps again. So, for example, if you are in a high tax bracket, and have no other capital gains, you might think of selling enough AGPH to realize a $3,000 loss, and keep the rest.

But, if I were you, I would hold now, since I suspect that a lot of investors are now doing exactly this, and thereby artifically depressing the price of AGPH stock. Tax loss selling in the biotechs this year has been brutal, from what I can tell. I would expect a rebound of stock price beginning 1/2/98. RR

Also, if you take your losses this year, and then buy back in next year, (and let's assume you get lucky and buy back in for the same price), you have lowered your tax basis in the stock (from which future capital gains are figured,) In other words, holding a $30,000 loss going into next year will allow you to make up to $30,000 appreciation on the stock (relative to where you are now), without paying any capital gains taxes.

RR